Seagen Investor Relations Material
Latest events
Q4 2022
Seagen
Q3 2023
1 Nov, 2023
Q2 2023
2 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Seagen Inc
Access all reports
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer. The company markets LONZA (vinorelbine tartrate) injection, which is used to treat various types of cancer. It also focuses on the development of Seaglass (poly-L-glutamic acid), a compound that is undergoing clinical study for the treatment of chemotherapy-induced nausea and vomiting (CINV). The company was formerly known as Ocean Pharmaceuticals, Inc. and changed its name to Seagen Inc. in August 1995. Seagen Inc. is based in Bothell, Washington.
Latest articles
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
)
Nintendo: From Game Boy and Pokémon to Switch 2 and Mario Kart
Nintendo went from card maker to cultural icon, shaping modern entertainment through hardware innovation and world-famous characters.
19 Jun 2025
Ticker symbol
SGEN
Country
🇺🇸 United States